Developmental Dental Defects Linked with Chemoradiotherapy: A Case Report.

Developmental orofacial dentoalveolar complications associated with chemoradiotherapy in an 8 year old child with a history of rhabdomyosarcoma are reported. This report details, clinically and radiographically, these effects in a child diagnosed at 3 years of age with a lesion primary to the left buccinator. Early evaluation is vital to determine potential dentoalveolar complications and long-term consequences.

chemotherapy, radiotherapy, dental defects, case.

1. Weber CO. Anatomische Untersuchung einer hypertrophischen Zunge nebst Bemerkungen uber die Neubildung quergestreifter Muskelfasern. Virchow Arch Pathol Anat, 7:15, 1854.

2. Kramer S, Meadows AT, Jarrett P et al. Incidence of childhood cancer: experience of a decade in a population-based registry. J Natl Cancer Inst, 170: 49–55, 1983.

3. Young JL, Ries LG, Silverberg E et al. Cancer incidence, survival and mortality for children younger than age 15 years. Cancer, 58(2): 598–602, 1986.

4. Wexler L, Helman L. Rhabdomyosarcoma and the undifferentiated sarcomas. In: Pizzo P, Poplack D, eds. Principles and Practice of Pediatric Oncology, 3rd Edition. Philadelphia: Lippincott-Raven; 799–829, 1997.

5. Crist W, Gehan EA, Ragab AH et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol, 13: 610–630, 1995.

6. Wiener ES. Head and neck rhabdomyosarcoma. Seminars in Pediatric Surgery, 3(3): 203–6, 1994.

7. Sessions DG, Ragab AH, Vietti TJ, Biller HF, Ogura JH. Embryonal RMS of the head and neck in children. Laryngoscope, 83: 890–7, 1973.

8. Liebner EJ. Embryonal rhabdomyosarcoma of head and neck in children. Cancer, 37: 2777–86, 1976.

9. Mehta S, Verma A, Mann SBS, Mehra YN, Sharma SC, Radotra BD. RMS of the head and neck-an analysis of 24 cases. Indian Journal of Cancer, 33: 37–42, 1996.

10. Pratt CB, Smith JW, Woemer S et al. Factors leading to delay in diagnosis and affecting survival of children with head and neck RMS. Pediatrics, 61(1): 30–4, 1978.

11. Gilles R, Couanet D, Sigal R et al. Head and neck RMS in children: value of clinical and CT findings in the detection of loco-regional relapses. Clinical Radiology, 49: 412–5, 1994.

12. Pavithran K, Doval D, Mukherjee G et al. Rhabdomyosarcaoma of the oral cavity: report of eight cases. Acta Oncologica, 36(8): 819–21, 1997.

13. Bras J, Batsakis JG, Luna MA. Rhabdomyosarcoma of the oral soft tissues. Oral Surg Oral Med Oral Pathol, 64: 585–96, 1987.

14. Peters E, Chen M, Altini M, Murray J. Rhabdomyosarcoma of the oral and para-oral region. Cancer, 63: 963–6, 1989.

15. Brookes CN, Van Veizen D. Rhabdomyosarcoma presenting as a facial swelling in a child. A case report and review of literature. British Journal of Oral and maxillofacial Surgery, 28: 117–21, 1990.

16. Wiss K, Solomon AR, Raimer SS, Lobe TE, Gourley W, Headington JT. Rhabdomyosarcoma presenting as a cutaneous nodule. Arch Dermatol, 124: 1687–90, 1988.

17. Enzinger FM, Weiss SW. Soft tissue tumors. 3rd Ed. St. Louis, MO: CV Mosby, 539–77, 1995.

18. Pappo AS, Shapiro DN, Crist WM. Rhabdomyosarcoma biology and treatment. Pediatric Oncology, 44(4): 953–71, 1997.

19. Parham DM. Pathologic classification of rhabdomyosarcomas and correlations with molecular studies. Mod Pathol, 14(5): 506–14, 2001.

20. Chigurupati R, Alfatooni A, Myall RW, Hawkins D, Oda D. Orofacial rhabdomyosarcoma in neonates and young children: a review of literature and management of four cases. Oral Oncol, 38(5): 508–15, 2002.

21. Wiener ES. Rhabdomyosarcoma. In: O’Neill JA, Rowe MI, Grosfeld JL et al., eds. Pediatric Surgery, 5th Edition. St Louis: Mosby; 431–445, 1998.

22. Rodriguez-Perales S, Martí nez-Ramí rez A, De André s SA, Valle L, Urioste M, Bení tez J et al. Molecular cytogenetic characterization of rhabdomyosarcoma cell lines. Cancer Genet Cytogenet, 148(1): 35–43, 2004.

23. Asakura A, Rudnicki MA. Rhabdomyosarcomagenesis-Novel pathway found. Cancer Cell, 4(6): 421–2, 2003.

24. Tobar A, Avigad S, Zoldan M, Mor C, Goshen Y, Zaizov R. Clinical relevance of molecular diagnosis in childhood rhabdomyosarcoma. Diagn Mol Pathol, 9(1): 9–13, 2000.

25. Pappo AS, Meza JL, Donaldson SS et al. Treatment of localized nonorbital, nonparameningeal head and neck rhabdomyosarcoma: lessons learned from intergroup rhabdomyosarcoma studies III and IV. J Clin Oncol, 21(4): 638–45, 2003.

26. Grundy R, Anderson J, Gaze M et al. Congenital Alveolar RMS clinical and molecular distinction from alveolar RMS in older children. Cancer, 91(3): 601–12, 2001.

27. Fayle S, Duggal M, Williams S. Oral problems and the dentist’s role in the management of Paediatric Oncology Patients. Dental Update, (May): 152–159, 1992.

28. Maguire A, Welbury R. Long-term effects of antineoplastic chemotherapy and radiotherapy on dental development. Dental Update, 23: 188–194, 1996.

29. Sicher H, Bhaskar SN. Orban’s oral histology and embryology, CV Mosby, St Louis; 31–51, 1962.

30. Paulino AC, Simon JH, Zhen W et al. Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys, 48(5): 1489–95, 2000.

31. Paulino AC. Role of radiation therapy in parameningeal rhabdomyosarcoma. Cancer Invest, 17(3): 223–30, 1999.

32. Maguire A, Craft AW, Evans RG et al. The long-term effects of treatment on the dental condition of children surviving malignant disease. Cancer, 60(10): 2570–5, 1987.

33. Jaffe N, Toth BB, Hoar RE, Ried HL, Sullivan MP, McNeese MD. Dental and maxillofacial abnormalities in long-term survivors of childhood cancer: effects of treatment with chemotherapy and radiation to the head and neck. Pediatrics, 73: 816–23, 1984.

34. Byrne JJ. The effect of ionizing irradiation on the developing maxilla and mandible. Am J Orthodontics, 47: 646–60, 1961.

35. Rapaport R, Oberfield SE, Robison L et al. Relationship of growth hormone deficiency and leukemia. J Pediatr, 126(1): 759–61, 1995.

36. Sklar CA. Growth and neuroendocrine dysfunction following therapy for childhood cancer. Pediatr Clin North Am, 44(2): 489–503, 1997.

37. Sanger RG, McTigue DJ. Sickle cell anemia: Its pathology and management. J Dent Handicap, 3: 9–21, 1978.

38. Alves PVM, Alves DKM, de Souza MMG, Torres SR. Orthodontic treatment of patients with sickle cell anemia. Angle Orthod, 76: 269–73, 2006.

39. Taylor LB, Nowak AJ, Giller RH, Casamassimo PS. Sickle cell anemia: A review of dental concerns and a retrospective study of dental and bony changes. Spec Care Dent, 15: 38–42, 1995.

40. Sebes JI, Diggs LW. Radiographic changes of the skull in sickle cell anemia. Am J Roentgenol, 132: 373–7, 1979.

41. Soni NN. Microradiographic study of dental tissues in sickle cell anemia. Arch Oral Biol, 11: 561–4, 1966.

42. Kavadia-Tsatala S, Kolokytha O, Kaklamanos EG et al. Mandibular lesions of vaso-occlusive origin in sickle cell hemoglobinopathy. Odontology, 92: 68–72, 2004.

43. Chen SY, Thakur A, Miller AS, Harwick RD. Rhabdomyosarcoma of the oral cavity. Report of four cases. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80(2): 192–201, 1995.